Antibody Engineering & Therapeutics Europe 2019

Antibody Engineering and Therapeutics Europe, Jun 11 - 13, 2019 in Amsterdam, is the #1 antibody meeting in Europe bringing together world-renowned scientists and academic researchers to deliver the latest science, technologies and partners needed to help you accelerate next generation antibodies towards commercial success.

Confirmed Keynotes:
• Hans Clevers, M.D., Ph.D., Group Leader, Hubrecht Institute for Developmental Biology and Stem Cell Research and Professor of Molecular Genetics, University Medical Center Utrecht and Utrecht University, The Netherlands
• Jane Osbourn, Ph.D., Vice President RandD and Site Leader of MedImmune, Cambridge, United Kingdom

Sessions Around 6 Key Themes:
• Turning Antibody Leads into Drugs
• Recent Advances in Immuno-Oncology Approaches
• Bioinformatics and Repertoires in Antibody Discovery and Development
• Antibody Therapeutics for Autoimmune and Neurodegenerative Diseases
• Clinical Developments in Antibody Therapeutics
• New Antibody Formats and Effector Functions

Don't Wait! This event sold out last year and had to be moved to a new venue this year!

Visit: AntibodyEngEu

Time: 8:00 am - 5:00 pm

Prices:
Industry - Conference Only: GBP 1399.0,
Academic - Conference Only: GBP 499.0

Speakers: Jane Osbourn, Ph.D. Vice President RandD and Site Leader at Medimmune, Hans Clevers, M.D., Ph.D. Group Leader and Professor of Molecular Genetics at Hubrecht Institute for Developmental Biology and Stem Cell Research and University Medical Center Utrecht and Utrecht University, Andreas Plückthun, PhD Professor and Director, Department of Biochemistry at University of Zurich

Additional details will be posted as soon as they are available.